OpenAlex
PricingAboutJobs
Log inGet started
Work

Influence of CYP2C19 Pharmacogenetic Polymorphism on Proton Pump Inhibitor-based Therapies

HTML

Year: 2005
Type: review
Source: Drug Metabolism and Pharmacokinetics
DOI: 10.2133/dmpk.20.153
Authors: Takahisa Furuta, Naohito Shirai, Mitsushige Sugimoto, Akiko Nakamura, Akira Hishida, Takashi Ishizaki
Institutions: Hamamatsu University School of Medicine, Hamamatsu University, Teikyo Heisei University
Language: English

Topic: Pharmacogenetics and Drug Metabolism
Subfield: Pharmacology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: CYP2C19, pharmacogenetics, proton pump inhibitors, omeprazole, lansoprazole, rabeprazole, esomeprazole, pantoprazole, CYP2C19 polymorphism, pharmacokinetics, pharmacodynamics, gastroesophageal reflux disease, Helicobacter pylori infection, dose optimization, gastric pH
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2056770708
FWCI: 1.669
Cites: 102
Cited by: 261
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms